ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

Although the antibody response to COVID-19 vaccination has been studied extensively at the polyclonal level using immune sera, little has been reported on the antibody response at the monoclonal level. Here, we isolate a panel of 44 anti-SARS-CoV-2 monoclonal antibodies (mAbs) from an individual who...

Descripción completa

Detalles Bibliográficos
Autores principales: Seow, Jeffrey, Graham, Carl, Hallett, Sadie R., Lechmere, Thomas, Maguire, Thomas J.A., Huettner, Isabella, Cox, Daniel, Khan, Hataf, Pickering, Suzanne, Roberts, Rebekah, Waters, Anele, Ward, Christopher C., Mant, Christine, Pitcher, Michael J., Spencer, Jo, Fox, Julie, Malim, Michael H., Doores, Katie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010245/
https://www.ncbi.nlm.nih.gov/pubmed/35477023
http://dx.doi.org/10.1016/j.celrep.2022.110757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010245/
https://www.ncbi.nlm.nih.gov/pubmed/35477023
http://dx.doi.org/10.1016/j.celrep.2022.110757

Ejemplares similares